Advertisement
Archival Report| Volume 70, ISSUE 1, P97-105, July 01, 2011

Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder

      Background

      There is conflicting evidence of whether polyunsaturated fatty acids (PUFA) in red blood cells are bimodally distributed in schizophrenia. The purpose of this study was to examine the distribution of PUFA, as well as its links to plausible causal factors.

      Methods

      A 16-week cohort study and a case-control study as part of a randomized controlled trial. Ninety-nine patients with DSM-IV schizophrenia, schizoaffective disorder, or schizophreniform disorder, aged 18 to 39, were consecutively included at admission to psychiatric departments of nine Norwegian hospitals. Fatty acids were measured in 97 of these patients and in 20 healthy control subjects. The primary outcome measure was the bimodality test statistic T, assessed by a χ2 test of the likelihood of one or two normal distributions of PUFA.

      Results

      At baseline, levels of polyunsaturated fatty acids were highly significantly bimodally distributed among patients. One third of patients constituted a group (low PUFA) who had PUFA levels at one fifth (p < .001) of those in high PUFA patients and healthy control subjects, which did not differ. Bimodality was mainly accounted for by docosahexaenoic acid and arachidonic acid. Bimodality was confirmed after 16 weeks. α-tocopherol was a robust predictor of PUFA at both occasions. Desaturase and elongase indexes differed between PUFA groups. Smoking, gender, antipsychotic medication, and dietary factors did not explain the bimodal distribution.

      Conclusions

      Red blood cell PUFA were bimodally distributed among acutely ill patients with schizophrenia and schizoaffective disorder. Endogenous deficiencies of redox regulation or synthesis of long-chain PUFA in the low PUFA group may explain our findings.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Horrobin D.F.
        • Glen A.I.M.
        • Vaddadi K.
        The membrane hypothesis of schizophrenia.
        Schizophr Res. 1994; 13: 195-207
        • Mahadik S.P.
        • Yao J.K.
        Phospholipids in schizophrenia.
        in: Lieberman J.A. Stroup T.S. Perkins D.O. Textbook of Schizophrenia. American Psychiatric Publishing, Washington, DC2006: 117-135
        • Do K.Q.
        • Cabungcal J.H.
        • Frank A.
        • Steullet P.
        • Cuenod M.
        Redox dysregulation, neurodevelopment, and schizophrenia.
        Curr Opin Neurobiol. 2009; 19: 220-230
        • Glen A.I.
        • Glen E.M.
        • Horrobin D.F.
        • Vaddadi K.S.
        • Spellman M.
        • Morse-Fisher N.
        • et al.
        A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases.
        Schizophr Res. 1994; 12: 53-61
        • Peet M.
        • Laugharne J.
        • Rangarajan N.
        • Horrobin D.
        • Reynolds G.
        Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients.
        J Psychiatr Res. 1995; 29: 227-232
        • Fox H.
        • Ross B.M.
        • Tocher D.
        • Horrobin D.
        • Glen I.
        • St. Clair D.
        Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20 degrees C proceeds faster in patients with schizophrenia when compared with healthy controls.
        Prostaglandins Leukot Essent Fatty Acids. 2003; 69: 291-297
        • Hibbeln J.R.
        • Makino K.K.
        • Martin C.E.
        • Dickerson F.
        • Boronow J.
        • Fenton W.S.
        Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder.
        Biol Psychiatry. 2003; 53: 431-441
        • Doehlert D.C.
        • McMullen M.S.
        • Jannink J.L.
        • Panigrahi S.
        • Gu H.
        • Riveland N.R.
        Evaluation of Oat Kernel Size Uniformity.
        Crop Sci. 2004; 44: 1178-1186
        • McLachlan G.
        • Peel D.
        Finite Mixture Models.
        John Wiley & Sons, New York2000
        • Yang Y.
        • Fan J.
        • May S.
        Bimodality of plasma glucose distributions in Whites: A bootstrap approach to testing mixture models.
        J Data Sci. 2010; 8: 483-493
        • R Development Core Team
        R: A Language and Environment for Statistical Computing.
        R Foundation for Statistical Computing, Vienna2008
        • Bender R.
        • Lange S.
        Adjusting for multiple testing–when and how?.
        J Clin Epidemiol. 2001; 54: 343-349
        • Fokkema M.R.
        • Smit E.N.
        • Martini I.A.
        • Woltil H.A.
        • Boersma E.R.
        • Muskiet F.A.
        Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3.
        Prostaglandins Leukot Essent Fatty Acids. 2002; 67: 345-356
        • Warensjo E.
        • Ohrvall M.
        • Vessby B.
        Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women.
        Nutr Metab Cardiovasc Dis. 2006; 16: 128-136
        • Slagsvold J.
        • Thorstensen K.
        • Kvitland M.
        • Erixon D.
        • Knagenhjelm N.
        • Mack M.
        • et al.
        Fatty acid desaturase expression in human leukocytes correlates with plasma phospholipid fatty acid status.
        Scand J Clin Lab Invest. 2009; 69: 496-504
        • Aasheim E.T.
        • Hofso D.
        • Hjelmesaeth J.
        • Birkeland K.I.
        • Bohmer T.
        Vitamin status in morbidly obese patients: A cross-sectional study.
        Am J Clin Nutr. 2008; 87: 362-369
        • Lieberman J.A.
        • Bymaster F.P.
        • Meltzer H.Y.
        • Deutch A.Y.
        • Duncan G.E.
        • Marx C.E.
        • et al.
        Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.
        Pharmacol Rev. 2008; 60: 358-403
        • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
        Consensus development conference on antipsychotic drugs and obesity and diabetes.
        Diabetes Care. 2004; 27: 596-601
        • Kut'ko I.I.
        • Frolov V.M.
        • Pustovoi I.G.
        • Rachkauskas G.S.
        • Pavlenko V.V.
        Antioxidants in the treatment of schizophrenia (the correction of lipid peroxidation processes).
        Zh Nevrol Psikhiatr Im S S Korsakova. 1996; 96: 32-34
        • Gama C.S.
        • Salvador M.
        • Andreazza A.C.
        • Lobato M.I.
        • Berk M.
        • Kapczinski F.
        • Belmonte-de-Abreu P.S.
        Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males.
        Neurosci Lett. 2008; 433: 270-273
        • Block G.
        • Dietrich M.
        • Norkus E.P.
        • Morrow J.D.
        • Hudes M.
        • Caan B.
        • Packer L.
        Factors associated with oxidative stress in human populations.
        Am J Epidemiol. 2002; 156: 274-285
        • Khan M.M.
        • Evans D.R.
        • Gunna V.
        • Scheffer R.E.
        • Parikh V.V.
        • Mahadik S.P.
        Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.
        Schizophr Res. 2002; 58: 1-10
        • Sands S.A.
        • Reid K.J.
        • Windsor S.L.
        • Harris W.S.
        The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes.
        Lipids. 2005; 40: 343-347
        • Reddy R.D.
        • Keshavan M.S.
        • Yao J.K.
        Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline.
        Schizophr Bull. 2004; 30: 901-911
        • Kropp S.
        • Kern V.
        • Lange K.
        • Degner D.
        • Hajak G.
        • Kornhuber J.
        • et al.
        Oxidative stress during treatment with first- and second-generation antipsychotics.
        J Neuropsychiatry Clin Neurosci. 2005; 17: 227-231
        • Akyol O.
        • Herken H.
        • Uz E.
        • Fadillioglu E.
        • Unal S.
        • Sogut S.
        • et al.
        The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients.
        Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26: 995-1005
        • Yao J.K.
        • Reddy R.
        • van Kammen D.P.
        Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.
        Psychiatry Res. 2000; 97: 137-151
        • Polymeropoulos M.H.
        • Licamele L.
        • Volpi S.
        • Mack K.
        • Mitkus S.N.
        • Carstea E.D.
        • et al.
        Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia.
        Schizophr Res. 2009; 108: 134-142
        • Evans D.R.
        • Parikh V.V.
        • Khan M.M.
        • Coussons C.
        • Buckley P.F.
        • Mahadik S.P.
        Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.
        Prostaglandins Leukot Essent Fatty Acids. 2003; 69: 393-399
        • Pillai A.
        • Parikh V.
        • Terry J.
        • Mahadik S.P.
        Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
        J Psychiatr Res. 2007; 41: 372-386
        • Arab L.
        Biomarkers of fat and fatty acid intake.
        J Nutr. 2003; 133: 925S-932S
        • Manku M.S.
        • Horrobin D.F.
        • Huang Y.S.
        • Morse N.
        Fatty acids in plasma and red cell membranes in normal humans.
        Lipids. 1983; 18: 906-908
        • Giltay E.J.
        • Gooren L.J.G.
        • Toorians A.W.F.T.
        • Katan M.B.
        • Zock P.L.
        Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects.
        Am J Clin Nutr. 2004; 80: 1167-1174
        • Zhang X.Y.
        • Tan Y.L.
        • Cao L.Y.
        • Wu G.Y.
        • Xu Q.
        • Shen Y.
        • Zhou D.F.
        Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
        Schizophr Res. 2006; 81: 291-300
        • Ranjekar P.K.
        • Hinge A.
        • Hegde M.V.
        • Ghate M.
        • Kale A.
        • Sitasawad S.
        • et al.
        Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.
        Psychiatry Res. 2003; 121: 109-122
        • Andersen L.F.
        • Solvoll K.
        • Johansson L.R.
        • Salminen I.
        • Aro A.
        • Drevon C.A.
        Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum.
        Am J Epidemiol. 1999; 150: 75-87
        • Saadatian-Elahi M.
        • Slimani N.
        • Chajes V.
        • Jenab M.
        • Goudable J.
        • Biessy C.
        • et al.
        Plasma phospholipid fatty acid profiles and their association with food intakes: Results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition.
        Am J Clin Nutr. 2009; 89: 331-346
        • Zhou L.
        • Nilsson A.
        Sources of eicosanoid precursor fatty acid pools in tissues.
        J Lipid Res. 2001; 42: 1521-1542
        • Mellor J.E.
        • Laugharne J.D.E.
        • Peet M.
        Omega-3 fatty acid supplementation in schizophrenic patients.
        Hum Psychopharmacol. 1996; 11: 39-46
        • Assies J.
        • Lieverse R.
        • Vreken P.
        • Wanders R.J.
        • Dingemans P.M.
        • Linszen D.H.
        Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
        Biol Psychiatry. 2001; 49: 510-522
        • Strassnig M.
        • Singh Brar J.
        • Ganguli R.
        Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia.
        Schizophr Res. 2005; 76: 343-351
        • Arvindakshan M.
        • Sitasawad S.
        • Debsikdar V.
        • Ghate M.
        • Evans D.
        • Horrobin D.F.
        • et al.
        Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.
        Biol Psychiatry. 2003; 53: 56-64
        • Yao J.K.
        • van Kammen D.P.
        • Welker J.A.
        Red blood cell membrane dynamics in schizophrenia.
        Schizophr Res. 1994; 13: 217-226
        • Traber M.G.
        Vitamin E regulatory mechanisms.
        Annu Rev Nutr. 2007; 27: 347-362
        • Foy C.J.
        • Passmore A.P.
        • Vahidassr M.D.
        • Young I.S.
        • Lawson J.T.
        Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.
        QJM. 1999; 92: 39-45
        • Charlton K.E.
        • Rabinowitz T.L.
        • Geffen L.N.
        • Dhansay M.A.
        Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients.
        J Nutr Health Aging. 2004; 8: 99-107
        • Clarke M.W.
        • Burnett J.R.
        • Croft K.D.
        Vitamin E in human health and disease.
        Crit Rev Clin Lab Sci. 2008; 45: 417-450
        • Morgan E.T.
        Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics.
        Clin Pharmacol Ther. 2009; 85: 434-438
        • Milne G.L.
        • Yin H.
        • Morrow J.D.
        Human biochemistry of the isoprostane pathway.
        J Biol Chem. 2008; 283: 15533-15537
        • Berdeaux O.
        • Scruel O.
        • Durand T.
        • Cracowski J.L.
        [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods].
        Pathol Biol (Paris). 2005; 53: 356-363
        • Michel F.
        • Bonnefont-Rousselot D.
        • Mas E.
        • Drai J.
        • Therond P.
        [Biomarkers of lipid peroxidation: Analytical aspects].
        Ann Biol Clin (Paris). 2008; 66: 605-620
        • Dietrich-Muszalska A.
        • Olas B.
        Isoprostenes as indicators of oxidative stress in schizophrenia.
        World J Biol Psychiatry. 2009; 10: 27-33
        • Basu S.
        • Helmersson J.
        Factors regulating isoprostane formation in vivo.
        Antioxid Redox Signal. 2005; 7: 221-235
        • Irizarry M.C.
        • Yao Y.
        • Hyman B.T.
        • Growdon J.H.
        • Pratico D.
        Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.
        Neurodegener Dis. 2007; 4: 403-405
        • Feillet-Coudray C.
        • Chone F.
        • Michel F.
        • Rock E.
        • Thieblot P.
        • Rayssiguier Y.
        • et al.
        Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes.
        Clin Chim Acta. 2002; 324: 25-30
        • Grignon S.
        • Chianetta J.M.
        Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations.
        Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31: 365-369
        • Skinner A.O.
        • Mahadik S.P.
        • Garver D.L.
        Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia.
        Schizophr Res. 2005; 76: 83-87
        • Yessoufou A.
        • Soulaimann N.
        • Merzouk S.A.
        • Moutairou K.
        • Ahissou H.
        • Prost J.
        • et al.
        N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.
        Int J Obes (Lond). 2006; 30: 739-750
        • Arab K.
        • Rossary A.
        • Flourie F.
        • Tourneur Y.
        • Steghens J.P.
        Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase.
        Br J Nutr. 2006; 95: 18-26
        • Richard D.
        • Kefi K.
        • Barbe U.
        • Bausero P.
        • Visioli F.
        Polyunsaturated fatty acids as antioxidants.
        Pharmacol Res. 2008; 57: 451-455
        • Nakamura M.T.
        • Nara T.Y.
        Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases.
        Annu Rev Nutr. 2004; 24: 345-376
        • Qin Y.
        • Dalen K.T.
        • Gustafsson J.A.
        • Nebb H.I.
        Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
        Biochim Biophys Acta. 2009; 1791: 140-147
        • Malerba G.
        • Schaeffer L.
        • Xumerle L.
        • Klopp N.
        • Trabetti E.
        • Biscuola M.
        • et al.
        SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease.
        Lipids. 2008; 43: 289-299
        • Rzehak P.
        • Heinrich J.
        • Klopp N.
        • Schaeffer L.
        • Hoff S.
        • Wolfram G.
        • et al.
        Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes.
        Br J Nutr. 2009; 101: 20-26
        • Tanaka T.
        • Shen J.
        • Abecasis G.R.
        • Kisialiou A.
        • Ordovas J.M.
        • Guralnik J.M.
        • et al.
        Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study.
        PLoS Genet. 2009; 5: e1000338
        • Xie L.
        • Innis S.M.
        Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation.
        J Nutr. 2008; 138: 2222-2228
        • Lattka E.
        • Illig T.
        • Heinrich J.
        • Koletzko B.
        Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?.
        Clin Nutr. 2010; 21: 64-69
        • Horrobin D.F.
        • Huang Y.S.
        Schizophrenia: The role of abnormal essential fatty acid and prostaglandin metabolism.
        Med Hypotheses. 1983; 10: 329-336
        • Mahadik S.P.
        • Shendarkar N.S.
        • Scheffer R.E.
        • Mukherjee S.
        • Correnti E.E.
        Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls.
        Prostaglandins Leukot Essent Fatty Acids. 1996; 55: 65-70
        • Liu Y.
        • Jandacek R.
        • Rider T.
        • Tso P.
        • McNamara R.K.
        Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: Relationship with fatty acid composition.
        Schizophr Res. 2009; 109: 113-120
        • Erkkila A.
        • de Mello V.D.
        • Riserus U.
        • Laaksonen D.E.
        Dietary fatty acids and cardiovascular disease: An epidemiological approach.
        Prog Lipid Res. 2008; 47: 172-187
        • Warensjo E.
        • Sundstrom J.
        • Vessby B.
        • Cederholm T.
        • Riserus U.
        Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: A population-based prospective study.
        Am J Clin Nutr. 2008; 88: 203-209
        • Murakami K.
        • Sasaki S.
        • Takahashi Y.
        • Uenishi K.
        • Watanabe T.
        • Kohri T.
        • et al.
        Lower estimates of delta-5 desaturase and elongase activity are related to adverse profiles for several metabolic risk factors in young Japanese women.
        Nutr Res. 2008; 28: 816-824
        • Suzuki T.
        • Delgado-Escueta A.V.
        • Alonso M.E.
        • Morita R.
        • Okamura N.
        • Sugimoto Y.
        • et al.
        Mutation analyses of genes on 6p12-p11 in patients with juvenile myoclonic epilepsy.
        Neurosci Lett. 2006; 405: 126-131